NSE · AETHER.NS
Aether Industries Limited
₹1,616.20+₹35.20 (+2.23%)
Aether Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.91% below the high.
Loading market information…
NSE · VINATIORGA.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Vinati Organics Limited’s quoted price sits in the lower half of its reported 52-week range, 41.77% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Vinati Organics Limited’s forward annual dividend is ₹8.50 per share, paid annual. The forward yield is 0.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Vinati Organics Limited’s next earnings report is currently expected on Oct 30, 2026, with estimated earnings per share of ₹10.43. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vinati Organics Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vinati Organics Limited, established in Mumbai, India in 1989, operates as a specialty chemical enterprise specializing in the production and global distribution of organic intermediaries and monomers. While primarily serving the Indian market, the company also exports its diverse product range to key international regions including the United States, Europe, and various parts of Asia. Its extensive portfolio features a variety of specialty monomers, such as 2-acrylamido-2-methylpropane sulphonic acid (2-AMPS) and its sodium salt, alongside N-tertiary butyl acrylamide (NTBA) and N-tertiary octyl acrylamide (NTOA). The company is also a significant producer of aromatic compounds. These include isobutyl benzene, a critical precursor for manufacturing ibuprofen, an anti-inflammatory analgesic drug; normal butyl benzene, utilized in the synthesis of numerous chemical intermediates; and hexenes, valued for applications like low-boiling point solvents, thinners, extraction agents, tire retreading, as octane boosters for gasoline, and in C5/C6 aliphatic petroleum. Butyl phenols are also part of this segment. Further expanding its chemical offerings, Vinati Organics provides methyl-4-tert butyl benzoate and para tertiary butyl benzoic acid. It manufactures isobutylene, a branched olefin; methanol, which functions as a chemical intermediate; and high-purity methyl tertiary butyl ether (MTBE), widely used as a solvent in organic and pharmaceutical synthesis, as well as in Grignard's reagent production. Tertiary-butylamine is another specialized chemical produced. Additionally, the firm develops polymers tailored for diverse industrial sectors, including construction, ceramics, oil drilling, mining, leather processing, and paper manufacturing.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:29 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2025 | May 15, 2025 | ₹12.00+1.95% vs estimate | ₹6.49B-2.89% vs estimate |
|---|
| Q3 2025 | Feb 1, 2025 | ₹9.10+10.98% vs estimate | ₹5.22B-3.1% vs estimate |
|---|
| Q2 2025 | Nov 12, 2024 | ₹10.06+14.32% vs estimate | ₹5.53B-0.44% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,616.20+₹35.20 (+2.23%)
Aether Industries Limited’s quoted price sits in the upper half of its reported 52-week range, 10.91% below the high.
₹435.75-₹6.30 (-1.43%)
Aarti Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 21.02% below the high.
₹1,143.50-₹38.50 (-3.26%)
Anupam Rasayan India Limited’s quoted price sits in the lower half of its reported 52-week range, 19.19% below the high.
₹1,589.90-₹63.90 (-3.86%)
Alkyl Amines Chemicals Limited’s quoted price sits in the lower half of its reported 52-week range, 24.83% below the high.
₹2,171.40-₹90.30 (-3.99%)
Neogen Chemicals Limited’s quoted price sits in the upper half of its reported 52-week range, 22.03% below the high.
₹1,765.80-₹83.00 (-4.49%)
Balaji Amines Limited’s quoted price sits in the lower half of its reported 52-week range, 32.85% below the high.
₹152.74-₹7.23 (-4.52%)
Laxmi Organic Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 25.05% below the high.
₹1,643.90+₹29.10 (+1.8%)
Tatva Chintan Pharma Chem Limited’s quoted price sits in the upper half of its reported 52-week range, 22.22% below the high.
